Definium Therapeutics US

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Definium Therapeutics US sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 4 currently recruiting 1 completed later-stage tilt upper quartile by trial count

Definium Therapeutics US: 6 sponsored US clinical trials, 4 recruiting.

Definium Therapeutics US sponsors 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 1 completed. 4 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Generalized Anxiety Disorder, with 2 trials.

Upper-quartile sponsor footprint

Definium Therapeutics US sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Where Definium Therapeutics US enrollment is open (later-stage tilt)

4 recruiting of 6 indexed (67% open); 1 completed (17%).

Phase mix: 4 late (III/IV) vs 2 early (I/II) (later-stage heavy).

Top condition: Generalized Anxiety Disorder (2 trials), 3 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Definium Therapeutics US: open-pipeline peers nationwide

Peers matched on 6 registered trials and 67% open enrollment, not the therapeutic-area sidebar.

Definium Therapeutics US sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 234567 0%20%40%60%80% Total trials Recruiting share Definium Therapeutics US23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchABL BioAccelerated Cure Project for Multiple SclerosisAdvanced Reconstructive Surgery AllianceAlexander B Olawaiye, MD
Definium Therapeutics US sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Definium Therapeutics US sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 67% open enrollment (± trial volume)

What to do with this Definium Therapeutics US page

6 registered trials is a research-attention snapshot, not an endorsement of Definium Therapeutics US or any single study.

  • 4 of Definium Therapeutics US's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Generalized Anxiety Disorder is the condition Definium Therapeutics US studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Generalized Anxiety Disorder trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Definium Therapeutics US pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.